| Administrative Supplements for Research on Dietary Supplements (Admin Supp)
|
|
Parent Announcements & Trans-NIH Announcements |
PA-18-817 |
P30, P40, P50 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
|
|
Bioinformatics, Computational Biology & Data Science, Oral, Oropharyngeal & Salivary Gland Cancers |
PA-17-239 |
R01 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
|
|
Bioinformatics, Computational Biology & Data Science, Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-17-243 |
R21 |
|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
PAR-18-541 |
U44 |
|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
|
|
Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Parent Announcements & Trans-NIH Announcements |
PAR-18-546 |
UG3, UH3 |
|
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
|
|
Behavioral & Social Science, Health Disparities |
PAR-17-464 |
R21 |
|
| Research to Improve Native American Health (R21 Clinical Trials Optional)
|
|
Clinical Research & Clinical Trials, Health Disparities |
PAR-17-464 |
R21 |
|
| Training Modules to Enhance the Rigor, Reproducibility and Responsible Conduct of Biomedical Data Science Research (R25 - Clinical Trial Not Allowed)
|
|
Bioinformatics, Computational Biology & Data Science, Career Development, Training & Fellowships |
RFA-GM-20-001 |
R25 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-17-475 |
R21 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-17-476 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional)
|
|
Behavioral & Social Science |
PAR-18-611 |
R21 |
|
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional)
|
|
Behavioral & Social Science |
PAR-18-612 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-845 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
|
|
Health Disparities, Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-846 |
R01 |
|
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)
|
|
Oral, Oropharyngeal & Salivary Gland Cancers |
PAR-18-848 |
R21 |
|
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional)
|
|
Oral Immunology, Immunopathology, and Immunotherapy, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-AT-21-001 |
R01 |
|
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional)
|
|
Oral Immunology, Immunopathology, and Immunotherapy, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-AT-21-002 |
R21 |
|
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
|
|
Clinical Research & Clinical Trials, HIV/AIDS and Oral Health |
PAR-18-190 |
R21 |
|
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
|
|
Clinical Research & Clinical Trials, HIV/AIDS and Oral Health |
PAR-18-189 |
R01 |
|
| Emerging Global Leader Award (K43 Independent Clinical Trial Required)
|
|
Career Development, Training & Fellowships |
PAR-19-038 |
K43 |
|
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
|
|
Career Development, Training & Fellowships |
PAR-19-098 |
K43 |
|
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
Related Notice
|
|
Global Health, Training & Fellowships |
PAR-18-901 |
D43 |
|
| Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
|
|
Clinical Research & Clinical Trials, Parent Announcements & Trans-NIH Announcements |
PAR-18-950 |
X02 |
|
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed)
|
|
Craniofacial & Dental Development, Disorders, Craniofacial Skeletal Biology & Pathobiology, Small Business (SBIR/STTR), Technology Development |
PA-18-609 |
R41, R42 |
|
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed)
|
|
Craniofacial & Dental Development, Disorders, Craniofacial Skeletal Biology & Pathobiology, Small Business (SBIR/STTR), Technology Development |
PA-18-610 |
R43, R44 |
|
